Salvage non-myeloablative allogeneic transplantation after failure of an autologous transplantation in multiple myeloma

被引：0
|
作者：
Qazilbash, MH [1 ]
Saliba, R [1 ]
Mendoza, F [1 ]
Roden, L [1 ]
Hosing, C [1 ]
Couriel, DE [1 ]
Kebriaci, W [1 ]
Popat, U [1 ]
De Lima, M [1 ]
Champlin, RE [1 ]
Giralt, SA [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.358
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
334
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [31] Autologous stem cell transplantation followed by non-myeloablative allogeneic procedure for oncohaematologic patients
    Salas, G
    Jurado-Chacón, M
    Romero, A
    Almagro, M
    Lopez, P
    Moratalla, A
    Navarro, P
    De Pablos, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S328 - S329
  • [32] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    P Campbell
    P Walker
    S Avery
    S Patil
    D Curtis
    A Schwarer
    A Wei
    A Kalff
    J Muirhead
    A Spencer
    Blood Cancer Journal, 2014, 4 : e213 - e213
  • [33] Partially HLA matched, non-myeloablative allogeneic transplantation
    Rizzieri, DA
    Koh, LP
    Long, GD
    Gasparetto, C
    Sullivan, KM
    Horwitz, M
    Chute, J
    Gong, JZ
    Lagoo, AS
    Niedzwiecki, D
    Lu, CX
    Marshall, D
    Dowell, JM
    Chao, NJ
    BLOOD, 2005, 106 (11) : 812A - 812A
  • [34] Second Transplants in Relapsed Multiple Myeloma (MM): Autologous (AHCT) Versus Non-Myeloablative/Reduced Intensity (NST/RIC) Allogeneic Transplantation (AlloHCT)
    Freytes, Cesar O.
    Vesole, David H.
    Zhong, Xiaobo
    Le-Rademacher, Jennifer
    Dispenzieri, Angela
    Lonial, Sagar
    Milone, Gustavo
    Hari, Parameswaran
    BLOOD, 2011, 118 (21) : 375 - 375
  • [35] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    Campbell, P.
    Walker, P.
    Avery, S.
    Patil, S.
    Curtis, D.
    Schwarer, A.
    Wei, A.
    Kalff, A.
    Muirhead, J.
    Spencer, A.
    BLOOD CANCER JOURNAL, 2014, 4 : e213 - e213
  • [36] Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
    de Donk, N. W. C. J. van
    Kroeger, N.
    Hegenbart, U.
    Corradini, P.
    Miguel, J. F. San
    Goldschmidt, H.
    Perez-Simon, J. A.
    Zijlmans, M.
    Raymakers, R. A.
    Montefusco, V.
    Ayuk, F. A.
    van Oers, M. H. J.
    Nagler, A.
    Verdonck, L. F.
    Lokhorst, H. M.
    BONE MARROW TRANSPLANTATION, 2006, 37 (12) : 1135 - 1141
  • [37] Treatment of multiple myeloma with an allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen
    Kmonicek, M
    Zak, P
    Jebavy, L
    Maisnar, V
    Maly, J
    BONE MARROW TRANSPLANTATION, 2003, 31 : S86 - S86
  • [38] Planned sequential autologous/non-myeloablative allogeneic peripheral stem cell transplantation in patients with newly diagnosed high-risk multiple myeloma
    Zinke-Cerwenka, W
    Neumeister, P
    Eibl, M
    Sill, H
    Emberger, W
    Wagner, T
    Wölfler, A
    Linkesch, W
    BONE MARROW TRANSPLANTATION, 2005, 35 : S387 - S388
  • [39] Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Relapsed After Initial Autologous Hematopoietic Cell Transplantation
    Byrne, Michael T.
    Dai, Yunfeng
    Moreb, Jan
    Wirk, Baldeep
    BLOOD, 2012, 120 (21)
  • [40] Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Relapsed After Initial Autologous Hematopoietic Cell Transplantation
    Wirk, Baldeep
    Byrne, Michael
    Dai, Yunfeng
    Moreb, Jan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S240 - S240
12345